Abstract
EE239 How to Consider Caregiver Health-Related Quality of Life in a Cost-Effectiveness Analysis? An Illustration with Dupilumab for the Treatment of Severe Atopic Dermatitis in Infants in France
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have